Evolent Health (EVH) Stock Statistics & Valuation Metrics

Evolent Health has a market cap or net worth of $1.04B. The enterprise value is $2.21B.

Evolent Health has 117,508,720 shares outstanding. The number of shares has decreased by -2.65% in one year.

Evolent Health’s return on equity (ROE) is -0.06 and return on invested capital (ROIC) is -1.93%.

The current PE Ratio of Evolent Health is ―. Evolent Health’s PEG ratio is ―.

In the last 12 months, Evolent Health had revenue of 2.55B and earned -61.62M in profits. Earnings per share was -0.81.

In the last 12 months, operating cash flow was -33.33M and capital expenditures -29.80M, giving a free cash flow of -63.13M billion.

Evolent Health pays an annual dividend of ―, resulting in a dividend yield of ―

Evolent Health upcoming earnings date is Oct 29, 2025, After Close (Confirmed).

Evolent Health as a current ratio of 0.85, with Debt / Equity ratio of 22.85%

In the past 12 months, Evolent Health has paid -1.41M in taxes.

Evolent Health EV to EBITDA ratio is 22.39, with an EV/FCF ratio of -309.99.

Evolent Health has $151.00M in cash and marketable securities with $204.74M in debt, giving a net cash position of $53.74M billion.

Gross margin is 15.31%, with operating margin of -1.58%, and net profit margin of -2.41%.

The average price target for Evolent Health is $14.89, which is 11.43% higher than the current price. The consensus rating is Strong Buy